Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ImagineMICtm Releases Advanced Patch Technology for Skilled Nursing Facilities


POUGHKEEPSIE, N.Y., Sept. 23, 2019 /PRNewswire/ -- ImagineMICtm announces the launch of a groundbreaking new telehealth solution to revolutionize patient care in skilled nursing environments. 

Unlike existing telemedicine platforms which allow for limited clinical evaluations, this new technology provides a telemedicine solution with real-time, actionable hemodynamic information through the combination of a wireless FDA-cleared Biosensor Telemetry Patch, working in tandem with the company's Monitoring Intervention Center (MIC), allowing for enhanced clinical decision-making. The MIC is staffed with a team of ER physicians, NPs, PAs and RNs who review this data 24/7/365, allowing for immediate, on-the-spot clinical decision-making.

The FDA-cleared wireless Biosensor Telemetry Patch can be easily placed on the chest of a resident, which captures, monitors and trends, in real-time, heart rate, respiratory rate, 2-lead ECG, skin temperature and orientation. 

"Most telemetry products on the market are reactive, ours is proactive," explains ImagineMICtm CEO and founder Dr. Anthony Bacchi. "Most products are simply 'Skyping' whereas our technology utilizes a combination of telemedicine and real-time hemodynamic data allowing for immediate real-time clinical intervention before a medical emergency, such as a rapid change in a resident's condition. Our company's technology used in conjunction with our MIC has proven to significantly reduce hospital readmissions and promote recovery." 

The ImagineMICtm patch and system is an ideal monitoring choice for health care facilities, providing continuous clinical oversight of patient's health while reducing operational and clinical costs. 

About ImagineMICtm

ImagineMICtm [from the creators of TeliStattm] is a revolutionary medical device company that offers medical care through remote monitoring services with the help of proprietary, HIPPA-compliant medical technology. To learn more, visit www.imagineMIC.com.

MEDIA CONTACT

ImagineMICtm
Rachel McIntosh 
845-389-1287
[email protected]

SOURCE ImagineMIC


These press releases may also interest you

at 22:54
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

More news about Health...


News published on and distributed by: